NM_001205293.3:c.951+11871C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001205293.3(CACNA1E):​c.951+11871C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.291 in 152,068 control chromosomes in the GnomAD database, including 6,582 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 6582 hom., cov: 31)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.194

Publications

7 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.346 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.951+11871C>T intron_variant Intron 6 of 47 ENST00000367573.7 NP_001192222.1 Q15878-1Q59FG1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.951+11871C>T intron_variant Intron 6 of 47 1 NM_001205293.3 ENSP00000356545.2 Q15878-1
CACNA1EENST00000360108.7 linkc.951+11871C>T intron_variant Intron 6 of 46 5 ENSP00000353222.3 F8W9Z1
CACNA1EENST00000367570.6 linkc.951+11871C>T intron_variant Intron 6 of 46 1 ENSP00000356542.1 Q15878-3
CACNA1EENST00000621791.4 linkc.951+11871C>T intron_variant Intron 6 of 45 1 ENSP00000481619.1 Q15878-2
CACNA1EENST00000524607.6 linkc.1386+11871C>T intron_variant Intron 8 of 11 5 ENSP00000432038.2 E9PIE8

Frequencies

GnomAD3 genomes
AF:
0.291
AC:
44259
AN:
151948
Hom.:
6568
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.255
Gnomad AMI
AF:
0.233
Gnomad AMR
AF:
0.353
Gnomad ASJ
AF:
0.317
Gnomad EAS
AF:
0.275
Gnomad SAS
AF:
0.264
Gnomad FIN
AF:
0.324
Gnomad MID
AF:
0.370
Gnomad NFE
AF:
0.296
Gnomad OTH
AF:
0.322
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.291
AC:
44297
AN:
152068
Hom.:
6582
Cov.:
31
AF XY:
0.290
AC XY:
21530
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.255
AC:
10586
AN:
41500
American (AMR)
AF:
0.354
AC:
5411
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.317
AC:
1101
AN:
3470
East Asian (EAS)
AF:
0.274
AC:
1419
AN:
5176
South Asian (SAS)
AF:
0.263
AC:
1266
AN:
4808
European-Finnish (FIN)
AF:
0.324
AC:
3417
AN:
10546
Middle Eastern (MID)
AF:
0.384
AC:
113
AN:
294
European-Non Finnish (NFE)
AF:
0.296
AC:
20100
AN:
67970
Other (OTH)
AF:
0.319
AC:
672
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1599
3197
4796
6394
7993
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
448
896
1344
1792
2240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.301
Hom.:
11910
Bravo
AF:
0.295
Asia WGS
AF:
0.309
AC:
1072
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
2.6
DANN
Benign
0.70
PhyloP100
-0.19
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3856094; hg19: chr1-181561783; API